Details for New Drug Application (NDA): 021504
✉ Email this page to a colleague
The generic ingredient in LIDOSITE TOPICAL SYSTEM KIT is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 021504
Tradename: | LIDOSITE TOPICAL SYSTEM KIT |
Applicant: | Vyteris |
Ingredient: | epinephrine; lidocaine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | PATCH;IONTOPHORESIS, TOPICAL | Strength | 1.05MG/PATCH;100MG/PATCH | ||||
Approval Date: | May 6, 2004 | TE: | RLD: | No |
Expired US Patents for NDA 021504
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 6,629,968 | ⤷ Subscribe |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 5,246,418 | ⤷ Subscribe |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 6,862,473 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription